Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Basilea Awarded $130 Million in Johnson & Johnson Dispute
Bloomberg
Monday, November 29, 2010 - 9:02am
tags:
JNJ, Basilea, settlements
Analysis: Pharma's woes not over, more restructuring seen
Reuters India
Sunday, November 28, 2010 - 11:57am
tags:
layoffs, restructuring
Ranbaxy to launch low-cost Alzheimer drug in US soon
Economic Times, India
Sunday, November 28, 2010 - 11:43am
tags:
Ranbaxy, Aricept, Eisai, Pfizer
Bad blood grows between Roche, Novartis CEOs
Sify, India
Sunday, November 28, 2010 - 11:40am
tags:
Roche, Novartis
Trophos and MS-Repair partners present promising data on novel approach in multiple sclerosis at SfN meeting
Pharmabiz
Sunday, November 28, 2010 - 11:36am
tags:
Trophos SA, MS-Repair, Olesoxime, multiple sclerosis
Drug Maker Cited on Quality Issues
NY Times
Sunday, November 28, 2010 - 11:33am
tags:
JNJ
Gilead: Preventing HIV Infection With a Pill
Seeking Alpha
Sunday, November 28, 2010 - 11:32am
tags:
Gilead Sciences, HIV, Truvada
Promising Data Puts Exelixis Back on Track
Seeking Alpha
Sunday, November 28, 2010 - 11:30am
tags:
Exelixis, XL184, cancer
Merck's Risky Bet on Heart Drugs May Yield Pills with Lipitor-Like Success
Bloomberg
Saturday, November 27, 2010 - 1:17pm
tags:
Merck, Pfizer, CETP inhibitors
Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Bloomberg
Saturday, November 27, 2010 - 1:15pm
tags:
Merck KGaA, FDA, MS, multiple sclerosis, Novartis, Darmstadt
Termeer Touts Campath-Linked CVRs
InVivo
Saturday, November 27, 2010 - 12:59pm
tags:
Henri Termeer, Campath, MS, Genzyme, multiple sclerosis, Sanofi
A $58M Loss: A Pfizer Prempro Appeal Is Denied
Pharmalot
Saturday, November 27, 2010 - 12:57pm
tags:
Pfizer, Wyeth, HRT, Prempro, appeals
Can Genzyme Make $3.5B a Year Giving Away a Drug for Free?
BNET Pharma
Saturday, November 27, 2010 - 12:53pm
tags:
Genzyme, alemtuzumab, Sanofi, MS, multiple sclerosis
Don't Get Too Worked Up Over Gilead's Earnings
Motley Fool
Saturday, November 27, 2010 - 12:33pm
tags:
Gilead Sciences, earnings
Virgin Market for New Bone Marrow Cancer Drug
Minyanville
Saturday, November 27, 2010 - 12:32pm
tags:
Incyte, myelofibrosis, YM BioSciences, CYT387, ONYX Pharmaceuticals
Sanofi leads drug stocks south
MarketWatch
Saturday, November 27, 2010 - 12:29pm
tags:
Sanofi
Genzyme open to Campath clause in Sanofi bid: report
Yahoo/Reuters
Saturday, November 27, 2010 - 12:28pm
tags:
Genzyme, Sanofi, M&A
Genzyme Lists Poison Pills, Talks to Other Companies, Termeer Tells Figaro
Bloomberg
Saturday, November 27, 2010 - 12:26pm
tags:
M&A, Genzyme, Sanofi
Sanofi Buyout Target Genzyme Meets First Deadline on Manufacturing Changes
Bloomberg
Wednesday, November 24, 2010 - 10:05am
tags:
M&A, Genzyme, Sanofi
Is Merck the Perfect Stock?
Motley Fool
Wednesday, November 24, 2010 - 8:34am
tags:
Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.